Ledger.Open graph →
SEC Form D · filed July 10, 2020

Gilgamesh Pharmaceuticals, Inc

Offering
—
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jonathan Sporn, M.D · New York, NYExec · DirectorThomas K. Murphy, Ph.D · New York, NYExecAndrew Kruegel, Ph.D · New York, NYExecBruce W. Schnitzer · Dallas, TXExecGreg G. Ezell · Dallas, TXExecDennis P. Lockhart · Dallas, TXExec · DirectorTimothy Drisdelle · Nashville, TNExec · DirectorRyan Wilson · Nolensville, TNExecJason Frantz · SAN FRANCISCO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗